DEMENTIA— OR SOMETHING ELSE
Lyme Science Blog
Jun 12

Can Lyme Disease Mimic Dementia? When Cognitive Decline May Be Reversible

Like
Visited 657 Times, 1 Visit today

Can Lyme Disease Mimic Dementia? When Cognitive Decline May Be Reversible

Lyme disease can cause memory loss, confusion, and cognitive decline that closely resembles dementia.
Unlike Alzheimer’s disease, Lyme-related cognitive symptoms may be driven by inflammation rather than permanent neurodegeneration.
In some cases, symptoms improve significantly following antibiotic treatment.

Can Lyme disease mimic dementia? Yes. Lyme disease can cause memory loss, confusion, and cognitive decline that may resemble dementia — and in some cases, these symptoms may improve with treatment.

Unlike Alzheimer’s disease or other neurodegenerative conditions, Lyme-related cognitive symptoms may be driven by inflammation and infection rather than permanent brain degeneration.

For a broader clinical overview of this overlap, see Lyme disease and dementia: when cognitive decline has another cause.

For a detailed overview of neurologic complications, see neurologic Lyme disease.


When Dementia Isn’t Dementia: Three Cases

Cognitive decline is often attributed to Alzheimer’s disease or other neurodegenerative disorders. However, some patients initially diagnosed with dementia are later found to have Lyme disease — a distinction that matters because one condition is progressive while the other may be reversible.

The following three cases illustrate how Lyme disease can present as apparent dementia — and how treatment changed the outcome.


Case 1: Kris Kristofferson

Country music legend Kris Kristofferson developed increasingly severe memory loss that doctors attributed to either Alzheimer’s disease or dementia caused by head trauma from boxing and contact sports in his youth. He reportedly could not remember what he was doing from one moment to the next.

However, Lyme disease testing came back positive. Once he stopped taking medication for Alzheimer’s and depression and began three weeks of Lyme disease treatment, the change was striking. His wife Lisa described him as suddenly being back — with some bad days, but also days when he was perfectly normal and it was easy to forget he was battling anything at all.

His case brought national attention to the possibility that some cases of apparent dementia may have a treatable infectious cause.


Case 2: The 81-Year-Old Retired Intelligence Officer

An 81-year-old retired case officer from the Defense Intelligence Agency — who had previously survived leukemia — was told he had dementia. Doctors believed he was suffering from a rapidly progressive and potentially fatal dementia, possibly an aggressive form of Alzheimer’s disease.

He became moody, confused, and delusional — a jarring contrast with the even-keeled, highly competent person he had been. He developed tremors, had trouble walking, and became incontinent.

After testing positive for Lyme disease, he began antibiotic treatment and made a full recovery.


Case 3: The 75-Year-Old Austrian Woman

A 75-year-old woman was admitted to a hospital in Austria with increasing malaise, abdominal discomfort, nausea, and constipation. She presented with a 10-month cognitive decline, low mood, loss of orientation to time, and impaired attention, concentration, and short-term memory.

Her examination revealed marked slowing of speech and movements, word-finding difficulties, rigidity and bradykinesia in the right arm, an unsteady broad-based gait, and mildly painful nuchal rigidity. Her MMSE score was 20 out of 30.

Brain MRI showed mild periventricular white matter changes and slight widening of the lateral ventricles — raising the possibility of early normal pressure hydrocephalus.

Several diagnoses were considered beyond dementia and normal pressure hydrocephalus, including the effects of long-standing drug treatment for depression, anxiety, headaches, and musculoskeletal pain, as well as mild head trauma from a motor vehicle accident 33 months earlier.

Lyme disease was diagnosed based on spinal fluid analysis. CSF evaluation revealed predominantly lymphocytic pleocytosis, elevated protein, oligoclonal bands, and a highly positive CSF/serum Borrelia-specific IgG index. Late Lyme neuroborreliosis was diagnosed according to current European guidelines.

The woman improved dramatically with three weeks of intravenous ceftriaxone. Three weeks after completing antibiotic therapy, her MMSE score rose from 20 to 28 out of 30 and all neurological signs resolved. The repeat CSF cleared. Her health remained well at 15-month follow-up.

This case highlights how Lyme disease can mimic structural brain conditions — and how a treatable infectious cause may be overlooked when imaging findings point toward a degenerative diagnosis.


Why Lyme Disease Can Affect Cognition

Lyme disease can affect the central nervous system through neuroinflammation, immune activation, and disruption of normal brain signaling.

These changes may result in memory loss, slowed thinking, difficulty concentrating, and behavioral changes — symptoms that may resemble dementia but arise from a different and potentially reversible mechanism.

These mechanisms are explored further in Lyme encephalopathy symptoms and complications.


Diagnostic Challenges

Diagnosing neurologic Lyme disease can be difficult. Spinal fluid abnormalities are not always present — Logigian and colleagues found that only 10% of 27 patients with chronic neurologic Lyme disease had abnormal spinal tap findings.

This means diagnosis often relies on clinical judgment rather than a single test — and that patients with normal spinal fluid may still have significant neurologic involvement.

See more on Lyme disease misdiagnosis and the broader diagnostic challenges that contribute to delayed care.


Not All Patients Recover Fully

While some patients improve dramatically following antibiotic treatment, others continue to experience persistent symptoms. Fallon and colleagues described patients with Lyme encephalopathy an average of nine years after treatment. Weitzner and colleagues reported that 11% of patients with Lyme disease suffered from post-treatment Lyme disease syndrome for more than 11 years.

This pattern is consistent with what is described as post-treatment Lyme disease syndrome (PTLDS), where symptoms may persist despite treatment.

Recovery varies depending on timing of diagnosis, duration of infection, and individual factors — underscoring the importance of early recognition.


Frequently Asked Questions

Can Lyme disease cause dementia-like symptoms?

Yes. Lyme disease can cause memory loss, confusion, slowed thinking, and behavioral changes that closely resemble dementia — particularly in older adults where cognitive decline is readily attributed to neurodegeneration.

Can Lyme-related cognitive decline be reversed?

In some cases, yes. Clinical cases including Kris Kristofferson and documented medical case reports show that cognitive symptoms attributed to dementia improved significantly following antibiotic treatment for Lyme disease.

How is Lyme-related cognitive decline different from Alzheimer’s disease?

Alzheimer’s disease reflects progressive structural neurodegeneration that worsens steadily over time. Lyme-related cognitive decline is driven by neuroinflammation and infection — it may fluctuate and in some cases improve when the underlying cause is treated.

What should prompt evaluation for Lyme disease in a patient with cognitive decline?

Rapid onset, fluctuating symptoms, coexisting systemic findings such as joint pain or fatigue, history of tick exposure, and failure to respond to standard dementia treatment should all prompt consideration of an infectious cause.


Clinical Takeaway

Lyme disease is one of several potentially reversible causes of cognitive decline. The cases of Kris Kristofferson, the retired intelligence officer, and the Austrian woman all illustrate how dementia-like presentations may have a treatable infectious cause that goes unrecognized when the diagnostic search stops too soon.

When patients present with dementia-like symptoms — especially when accompanied by neurologic or systemic features, rapid onset, or failure to respond to standard treatment — infectious causes including Lyme disease deserve consideration.

Recognizing that some cases of apparent dementia may have a treatable infectious cause can lead to earlier diagnosis, appropriate treatment, and meaningful recovery — outcomes that are lost when cognitive decline is assumed to be irreversible.


Related Articles


References

  1. Strauss N. Kris Kristofferson: An Outlaw at 80. Rolling Stone. June 6, 2016.
  2. Topakian R, Artemian H, Metschitzer B, Lugmayr H, Kuhr T, Pischinger B. Dramatic response to a 3-week course of ceftriaxone in late neuroborreliosis mimicking atypical dementia and normal pressure hydrocephalus. J Neurol Sci. 2016;366:146-148.
  3. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med. 1990;323(21):1438-1444.
  4. Fallon BA, Keilp JG, Corbera KM et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70(13):992-1003.
  5. Weitzner E, Visintainer P, Wormser GP. Comparison of males versus females with culture-confirmed early Lyme disease at presentation and at 11-20 years after diagnosis. Diagn Microbiol Infect Dis. 2016;85(4):493-495.

Dr. Daniel Cameron, MD, MPH
Lyme disease clinician with over 30 years of experience and past president of ILADS.

SymptomsTestingCoinfectionsRecoveryPediatricPrevention

Related Posts

Leave a Comment

Your email address will not be published. Required fields are marked *